Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127199) titled 'Efficacy of Early Administration of Human Intravenous Immunoglobulin for Kawasaki Disease in Children: A Multicenter, Prospective, Randomized Controlled Clinical Trial' on June 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangzhou Women and Children's Medical Center,Guangzhou Medical University
Condition:
Kawasaki Disease
Intervention:
Experimental (early treatment) group:Intravenous immunoglobulin (IVIG) was administered within 4 days of disease onset.
Phase: N/A
Date of First Enrollment: 2026-06-27
Target Sample Size: Experimental (early treatment) group:35;Control (s...